Nathan T. Douthit

Nathan T. Douthit

Auto-generated profile, based on publicly available information

Nathan T. Douthit

Brookwood Baptist Health Medical Education, Birmingham, AL, USA.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Public Health
Verified
Journal Article
Closed access
NDN. Douthit
N. Douthit
SKS. Kiv
S. Kiv
Tzvi DwolatzkyTzvi Dwolatzky
Tzvi Dwolatzky
SBS. Biswas
S. Biswas

5 March 2020 in Cureus
Verified
Journal Article
Open access
PDF file
AGAjay K. Gade
Ajay K. Gade
EOEva Olariu
Eva Olariu
NDNathan T. Douthit
Nathan T. Douthit
Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark symptoms of carcinoid syndrome are flushing and diarrhea; atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra, and the complications of mesenteric fibrosis, including ureteral obstruction, bowel obstruction, and bowel ischemia. These symptoms are mediated by the release of serotonin (5-HT), histamine, kallikrein, prostaglandins, and tachykinins. The diagnosis of CS requires these symptoms and corresponding elevations in lab tests. Treatment options include surgery and medical management with somatostatin analogs.

29 May 2020 in Cureus
Verified
Journal Article
Open access
PDF file
AGAjay K. Gade
Ajay K. Gade
NDNathan T. Douthit
Nathan T. Douthit
ETErin Townsley
Erin Townsley
Crohn's disease (CD) is a chronic inflammatory bowel disease that can affect the entire gastrointestinal tract from the mouth to the anus, sparing the rectum. The goal of medical therapy is to induce remission with medications, followed by the administration of maintenance medications to prevent a relapse of the disease. The concept of induction of remission and maintenance of remission is very important, as there is an overlap of medications used to induce and maintain remission. Physicians first direct treatment to induce a remission that involves relief of symptoms and mucosal healing of the lining of the colon and then provide long-term treatment to maintain the remission. Standard treatment for CD depends on the extent of involvement and disease severity, for example, mild, moderate, severe, and fulminant.

6 August 2019 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
NDNathan T. Douthit
Nathan T. Douthit
COChristopher Old
Christopher Old
Renal replacement therapy is guaranteed for all US citizens with end-stage renal disease (ESRD). Undocumented immigrants with ESRD are a particularly vulnerable subset of renal failure patients. There is no federal legislation for these patients except for the requirement to treat them during “emergency medical conditions” and federal legislation excluding them from the guarantee of renal replacement therapy described above. Different states have developed different methods for dealing with this problem, with variation in management even addressed on a center by center basis. This review of the original studies published in the literature reveals the medical, ethical, and financial problems with this situation. These patients frequently have delayed presentation to care, poor access to routine care, increased complications, increased utilization of services, and increased morbidity and mortality in an emergent dialysis model compared to chronic outpatient care. They present an ethical dilemma for practitioners who know they are providing substandard care and occasionally making decisions on how to allocate resources. Emergent dialysis is associated with inadequate reimbursement, increased threat to sustained unemployment, and an overburdening of our healthcare infrastructure. This practice puts patients at risk, places an unfair ethical burden on providers and is financially unsustainable. Special considerations described for kidney transplant and peritoneal dialysis are considered and considerations for a new model are reviewed in the paper. Ultimately accommodations must be made with the input of government, healthcare practitioners, and facilities needs to be reached to protect these vulnerable patients.

22 June 2016 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
NDNathan T Douthit
Nathan T Douthit
HAHaimanot Kasahun Alemu
Haimanot Kasahun Alemu
This case presentation of a 19-year-old Ethiopian woman diagnosed with nasopharyngeal carcinoma reveals the barriers the patient has to medical treatment, including poverty and a lack of national infrastructure. The patient lives a life of poverty, and the outcome of her illness is a result of her being unable to overcome barriers to accessing health care due to inability to afford transport, lodging and treatment. In this case, the patient's vulnerability to disease due to her poverty is not overcome because of lack of infrastructure. The infrastructure fails to develop because of inadequate investment and other delays in building. The end result is that the patient is vulnerable to disease. Her disease process impacts her family and their contribution to Ethiopia's development.

1 November 2023 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
JBJonathan Blackmon
Jonathan Blackmon
LBLindsey Blackmon
Lindsey Blackmon
CGClaire Goode
Claire Goode
NDNathan Douthit
Nathan Douthit